Exploring pharmacological strategies in the management of ARDS: Efficacy, limitations, and future directions

Almuntashiri, Sultan

doi:10.2478/jccm-2025-0030

References

Meyer NJ, Gattinoni L and Calfee CS. Acute respiratory distress syndrome. Lancet 2021; 398: 622–637. 2021/07/05. DOI: 10.1016/S0140-6736(21)00439-6.
Open DOI Search in Google Scholar Back to article
Peng M, Yan QH, Gao Y, et al. Correlation between circulating endothelial cell level and acute respiratory distress syndrome in postoperative patients. World J Clin Cases 2021; 9: 9731–9740. 2021/12/09. DOI: 10.12998/wjcc.v9.i32.9731.
Open DOI Search in Google Scholar Back to article
Banavasi H, Nguyen P, Osman H, et al. Management of ARDS - What Works and What Does Not. Am J Med Sci 2021; 362: 13–23. 2021/06/07. DOI: 10.1016/j.amjms.2020.12.019.
Open DOI Search in Google Scholar Back to article
Qadir N, Sahetya S, Munshi L, et al. An Update on Management of Adult Patients with Acute Respiratory Distress Syndrome: An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med 2024; 209: 24–36. 2023/11/30. DOI: 10.1164/rccm.202311-2011ST.
Open DOI Search in Google Scholar Back to article
Steinberg KP, Hudson LD, Goodman RB, et al. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 2006; 354: 1671–1684. 2006/04/21. DOI: 10.1056/NEJMoa051693.
Open DOI Search in Google Scholar Back to article
Meduri GU, Golden E, Freire AX, et al. Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest 2007; 131: 954–963. 2007/04/12. DOI: 10.1378/chest.06-2100.
Open DOI Search in Google Scholar Back to article
Meduri GU, Headley AS, Golden E, et al. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA 1998; 280: 159–165. 1998/07/21. DOI: 10.1001/jama.280.2.159.
Open DOI Search in Google Scholar Back to article
Villar J, Ferrando C, Martinez D, et al. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. Lancet Respir Med 2020; 8: 267–276. 2020/02/12. DOI: 10.1016/S2213-2600(19)30417-5.
Open DOI Search in Google Scholar Back to article
Tomazini BM, Maia IS, Cavalcanti AB, et al. Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial. JAMA 2020; 324: 1307–1316. 2020/09/03. DOI: 10.1001/jama.2020.17021.
Open DOI Search in Google Scholar Back to article
Papazian L, Forel JM, Gacouin A, et al. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 2010; 363: 1107–1116. 2010/09/17. DOI: 10.1056/NEJMoa1005372.
Open DOI Search in Google Scholar Back to article
National Heart L, Blood Institute PCTN, Moss M, et al. Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome. N Engl J Med 2019; 380: 1997–2008. 2019/05/22. DOI: 10.1056/NEJMoa1901686.
Open DOI Search in Google Scholar Back to article
Forel JM, Roch A, Marin V, et al. Neuromuscular blocking agents decrease inflammatory response in patients presenting with acute respiratory distress syndrome. Crit Care Med 2006; 34: 2749–2757. 2006/08/26. DOI: 10.1097/01.CCM.0000239435.87433.0D.
Open DOI Search in Google Scholar Back to article
Gainnier M, Roch A, Forel JM, et al. Effect of neuromuscular blocking agents on gas exchange in patients presenting with acute respiratory distress syndrome. Crit Care Med 2004; 32: 113–119. 2004/01/07. DOI: 10.1097/01.CCM.0000104114.72614.BC.
Open DOI Search in Google Scholar Back to article
Perkins GD, McAuley DF, Thickett DR, et al. The beta-agonist lung injury trial (BALTI): a randomized placebo-controlled clinical trial. Am J Respir Crit Care Med 2006; 173: 281–287. 2005/10/29. DOI: 10.1164/rccm.200508-1302OC.
Open DOI Search in Google Scholar Back to article
National Heart L, Blood Institute Acute Respiratory Distress Syndrome Clinical Trials N, Matthay MA, et al. Randomized, placebo-controlled clinical trial of an aerosolized beta(2)-agonist for treatment of acute lung injury. Am J Respir Crit Care Med 2011; 184: 561–568. 2011/05/13. DOI: 10.1164/rccm.201012-2090OC.
Open DOI Search in Google Scholar Back to article
Gao Smith F, Perkins GD, Gates S, et al. Effect of intravenous beta-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial. Lancet 2012; 379: 229–235. 2011/12/15. DOI: 10.1016/S0140-6736(11)61623-1.
Open DOI Search in Google Scholar Back to article
Chaudhuri D, Nei AM, Rochwerg B, et al. 2024 Focused Update: Guidelines on Use of Corticosteroids in Sepsis, Acute Respiratory Distress Syndrome, and Community-Acquired Pneumonia. Crit Care Med 2024; 52: e219–e233. 2024/01/19. DOI: 10.1097/CCM.0000000000006172.
Open DOI Search in Google Scholar Back to article
Landolf KM, Lemieux SM, Rose C, et al. Corticosteroid use in ARDS and its application to evolving therapeutics for coronavirus disease 2019 (COVID-19): A systematic review. Pharmacotherapy 2022; 42: 71–90. 2021/10/19. DOI: 10.1002/phar.2637.
Open DOI Search in Google Scholar Back to article
Patel R, Magomedova L, Tsai R, et al. Separating the Anti-Inflammatory and Diabetogenic Effects of Glucocorticoids Through LXRbeta Antagonism. Endocrinology 2017; 158: 1034–1047. 2017/03/23. DOI: 10.1210/en.2017-00094.
Open DOI Search in Google Scholar Back to article
Johnson DB, Lopez MJ and Kelley B. Dexamethasone. StatPearls. Treasure Island (FL) ineligible companies. Disclosure: Michael Lopez declares no relevant financial relationships with ineligible companies. Disclosure: Brendan Kelley declares no relevant financial relationships with ineligible companies., 2024.
Search in Google Scholar Back to article
Vassiliou AG, Athanasiou N, Vassiliadi DA, et al. Glucocorticoid and mineralocorticoid receptor expression in critical illness: A narrative review. World J Crit Care Med 2021; 10: 102–111. 2021/07/29. DOI: 10.5492/wjccm.v10.i4.102.
Open DOI Search in Google Scholar Back to article
Group RC, Horby P, Lim WS, et al. Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med 2021; 384: 693–704. 2020/07/18. DOI: 10.1056/NEJMoa2021436.
Open DOI Search in Google Scholar Back to article
Schoenfeld DA, Bernard GR and Network A. Statistical evaluation of ventilator-free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome. Crit Care Med 2002; 30: 1772–1777. 2002/08/07. DOI: 10.1097/00003246-200208000-00016.
Open DOI Search in Google Scholar Back to article
Sharma S. Acute respiratory distress syndrome. BMJ Clin Evid 2010; 2010 2010/01/01.
Search in Google Scholar Back to article
Taher A, Lashkari M, Keramat F, et al. Comparison of the efficacy of equivalent doses of dexamethasone, methylprednisolone, and hydrocortisone for treatment of COVID-19-related acute respiratory distress syndrome: a prospective three-arm randomized clinical trial. Wien Med Wochenschr 2023; 173: 140–151. 2023/01/10. DOI: 10.1007/s10354-022-00993-4.
Open DOI Search in Google Scholar Back to article
Maskin LP, Bonelli I, Olarte GL, et al. High-Versus Low-Dose Dexamethasone for the Treatment of COVID-19-Related Acute Respiratory Distress Syndrome: A Multicenter, Randomized Open-Label Clinical Trial. J Intensive Care Med 2022; 37: 491–499. 2021/12/14. DOI: 10.1177/08850666211066799.
Open DOI Search in Google Scholar Back to article
Villar J, Perez-Mendez L, Blanco J, et al. A universal definition of ARDS: the PaO₂/FiO₂ ratio under a standard ventilatory setting--a prospective, multicenter validation study. Intensive Care Med 2013; 39: 583–592. 2013/02/02. DOI: 10.1007/s00134-012-2803-x.
Open DOI Search in Google Scholar Back to article
Moreno R, Rhodes A, Piquilloud L, et al. The Sequential Organ Failure Assessment (SOFA) Score: has the time come for an update? Crit Care 2023; 27: 15. 2023/01/14. DOI: 10.1186/s13054-022-04290-9.
Open DOI Search in Google Scholar Back to article
Lee HS, Lee JM, Kim MS, et al. Low-dose steroid therapy at an early phase of postoperative acute respiratory distress syndrome. Ann Thorac Surg 2005; 79: 405–410. 2005/02/01. DOI: 10.1016/j.athoracsur.2004.07.079.
Open DOI Search in Google Scholar Back to article
Zhang Z, Chen L and Ni H. The effectiveness of Corticosteroids on mortality in patients with acute respiratory distress syndrome or acute lung injury: a secondary analysis. Sci Rep 2015; 5: 17654. 2015/12/03. DOI: 10.1038/srep17654.
Open DOI Search in Google Scholar Back to article
Pinzon MA, Ortiz S, Holguin H, et al. Dexamethasone vs methylprednisolone high dose for Covid-19 pneumonia. PLoS One 2021; 16: e0252057. 2021/05/26. DOI: 10.1371/journal.pone.0252057.
Open DOI Search in Google Scholar Back to article
Weigelt JA, Norcross JF, Borman KR, et al. Early steroid therapy for respiratory failure. Arch Surg 1985; 120: 536–540. 1985/05/01. DOI: 10.1001/archsurg.1985.01390290018003.
Open DOI Search in Google Scholar Back to article
Rocco PR, Souza AB, Faffe DS, et al. Effect of corticosteroid on lung parenchyma remodeling at an early phase of acute lung injury. Am J Respir Crit Care Med 2003; 168: 677–684. 2003/07/05. DOI: 10.1164/rccm.200302-256OC.
Open DOI Search in Google Scholar Back to article
Kehrer JP, Klein-Szanto AJ, Sorensen EM, et al. Enhanced acute lung damage following corticosteroid treatment. Am Rev Respir Dis 1984; 130: 256–261. 1984/08/01. DOI: 10.1164/arrd.1984.130.2.256.
Open DOI Search in Google Scholar Back to article
Hakkinen PJ, Schmoyer RL and Witschi HP. Potentiation of butylated-hydroxytoluene-induced acute lung damage by oxygen. Effects of prednisolone and indomethacin. Am Rev Respir Dis 1983; 128: 648–651. 1983/10/01. DOI: 10.1164/arrd.1983.128.4.648.
Open DOI Search in Google Scholar Back to article
Bernard GR, Luce JM, Sprung CL, et al. High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med 1987; 317: 1565–1570. 1987/12/17. DOI: 10.1056/NEJM198712173172504.
Open DOI Search in Google Scholar Back to article
Tongyoo S, Permpikul C, Mongkolpun W, et al. Hydrocortisone treatment in early sepsis-associated acute respiratory distress syndrome: results of a randomized controlled trial. Crit Care 2016; 20: 329. 2016/10/16. DOI: 10.1186/s13054-016-1511-2.
Open DOI Search in Google Scholar Back to article
Cook D and Simons DJ. Neuromuscular Blockade. StatPearls. Treasure Island (FL) ineligible companies. Disclosure: David Simons declares no relevant financial relationships with ineligible companies., 2024.
Search in Google Scholar Back to article
Mefford B, Donaldson JC and Bissell BD. To Block or Not: Updates in Neuromuscular Blockade in Acute Respiratory Distress Syndrome. Ann Pharmacother 2020; 54: 899–906. 2020/03/01. DOI: 10.1177/1060028020910132.
Open DOI Search in Google Scholar Back to article
Alhazzani W, Belley-Cote E, Moller MH, et al. Neuromuscular blockade in patients with ARDS: a rapid practice guideline. Intensive Care Med 2020; 46: 1977–1986. 2020/10/27. DOI: 10.1007/s00134-020-06227-8.
Open DOI Search in Google Scholar Back to article
Fanelli V, Morita Y, Cappello P, et al. Neuromuscular Blocking Agent Cisatracurium Attenuates Lung Injury by Inhibition of Nicotinic Acetylcholine Receptor-alpha1. Anesthesiology 2016; 124: 132–140. 2015/11/06. DOI: 10.1097/ALN.0000000000000907.
Open DOI Search in Google Scholar Back to article
Sparr HJ, Beaufort TM and Fuchs-Buder T. Newer neuromuscular blocking agents: how do they compare with established agents? Drugs 2001; 61: 919–942. 2001/07/04. DOI: 10.2165/00003495-200161070-00003.
Open DOI Search in Google Scholar Back to article
Sottile PD, Kiser TH, Burnham EL, et al. An Observational Study of the Efficacy of Cisatracurium Compared with Vecuronium in Patients with or at Risk for Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med 2018; 197: 897–904. 2017/12/15. DOI: 10.1164/rccm.201706-1132OC.
Open DOI Search in Google Scholar Back to article
Vallabh P, Ha M and Ahern K. Efficacy and Safety of Cisatracurium Compared to Vecuronium for Neuromuscular Blockade in Acute Respiratory Distress Syndrome. J Intensive Care Med 2023; 38: 188–195. 2022/07/14. DOI: 10.1177/08850666221113504.
Open DOI Search in Google Scholar Back to article
Moore L, Kramer CJ, Delcoix-Lopes S, et al. Comparison of Cisatracurium Versus Atracurium in Early ARDS. Respir Care 2017; 62: 947–952. 2017/03/30. DOI: 10.4187/respcare.05102.
Open DOI Search in Google Scholar Back to article
Carabetta SM, Allen B, Cannon C, et al. Atracurium Versus Cisatracurium in the Treatment of Acute Respiratory Distress Syndrome. J Pharm Technol 2023; 39: 212–217. 2023/09/25. DOI: 10.1177/87551225231194031.
Open DOI Search in Google Scholar Back to article
Pan X, Liu J, Zhang S, et al. Application of Neuromuscular Blockers in Patients with ARDS in ICU: A Retrospective Study Based on the MIMIC-III Database. J Clin Med 2023; 12 2023/03/12. DOI: 10.3390/jcm12051878.
Open DOI Search in Google Scholar Back to article
Groshaus HE, Manocha S, Walley KR, et al. Mechanisms of beta-receptor stimulation-induced improvement of acute lung injury and pulmonary edema. Crit Care 2004; 8: 234–242. 2004/08/18. DOI: 10.1186/cc2875.
Open DOI Search in Google Scholar Back to article
Mutlu GM and Factor P. Alveolar epithelial beta2-adrenergic receptors. Am J Respir Cell Mol Biol 2008; 38: 127–134. 2007/08/22. DOI: 10.1165/rcmb.2007-0198TR.
Open DOI Search in Google Scholar Back to article
Sartori C and Matthay MA. Alveolar epithelial fluid transport in acute lung injury: new insights. Eur Respir J 2002; 20: 1299–1313. 2002/11/27. DOI: 10.1183/09031936.02.00401602.
Open DOI Search in Google Scholar Back to article
Almuntashiri S, Chase A, Sikora A, et al. The Potential Synergistic Risk of Albuterol and Vasoactives in Acute Lung Injury Trials. Ann Pharmacother 2023; 57: 757–761. 2022/10/04. DOI: 10.1177/10600280221128014.
Open DOI Search in Google Scholar Back to article

Exploring pharmacological strategies in the management of ARDS: Efficacy, limitations, and future directions

References

Paradigm

My account